Drug class in one race
Kv7 potassium channel drugs for Epilepsy
3 tracked Kv7 potassium channel drugs in the Epilepsy race. The class explanation lives on the Kv7 potassium channel page; the full indication pipeline across every mechanism is on the Epilepsy page.
1 approved / phase 41 Phase 31 Phase 2/3
Head-to-head evidence: Azetukalner vs Ezogabine · Azetukalner vs Opakalim · Ezogabine vs Opakalim